.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Fuji
Cipla
US Department of Justice
Mallinckrodt
UBS
Fish and Richardson
Merck
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075987

« Back to Dashboard

NDA 075987 describes OXAPROZIN, which is a drug marketed by Actavis Elizabeth, Amneal Pharms Co, Apotex Inc, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Mylan Pharms Inc, Sandoz, Sun Pharm Inds Inc, Teva, and Watson Labs, and is included in thirteen NDAs. It is available from twenty suppliers. Additional details are available on the OXAPROZIN profile page.

The generic ingredient in OXAPROZIN is oxaprozin. There are thirteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the oxaprozin profile page.

Summary for 075987

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075987

Suppliers and Packaging for NDA: 075987

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OXAPROZIN oxaprozin TABLET;ORAL 075987 ANDA Apotex Corp. 60505-0176 60505-0176-1 500 TABLET, FILM COATED in 1 BOTTLE (60505-0176-1)
OXAPROZIN oxaprozin TABLET;ORAL 075987 ANDA Apotex Corp. 60505-0176 60505-0176-0 100 TABLET, FILM COATED in 1 BOTTLE (60505-0176-0)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength600MG
Approval Date:Sep 2, 2004TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Moodys
Dow
Chubb
Mallinckrodt
Harvard Business School
UBS
Baxter
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot